Changes in serum estrogen levels in women during tamoxifen therapy

American Journal of Surgery

Volumn 173, Issue 5, 1997, Pages 399-402

  Lum, Sharon S ^a   Woltering, Eugene A ^b   Fletcher, William S ^a   Pommier, Rodney F ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; PRASTERONE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ESTROGEN ACTIVITY; ESTROGEN BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MENOPAUSE; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DEHYDROEPIANDROSTERONE; ESTRADIOL; ESTROGENS; ESTRONE; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; PROSPECTIVE STUDIES; TAMOXIFEN;

EID: 0030969253     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(97)00072-X     Document Type: Article

References (21)

1. Pommier RF, Woltering EA, Keenan EJ, et al. The mechanism of hormone-sensitive breast cancer progression on antiestrogen therapy. Arch Surg. 1987;122:1311-1316.
2. Dnistrian AM, Greenberg EJ, Dillon HJ, et al. Chemohormonal therapy and endocrine function in breast cancer patients. Cancer. 1985;56:63-70.
3. Golder MP, Phillips MEA, Fahmy Dr, et al. Plasma hormones in patients with advanced breast cancer treated with tamoxifen. Europ J Cancer. 1976;12:719-723.
4. Szamel I, Vincze B, Hindy I, et al. Hormonal changes during a prolonged tamoxifen treatment in patients with advanced breast cancer. Oncology. 1986;43:7-11.
5. Lonning PE, Lien EA, Lundgren S, et al. Clinical pharmacokinetics of endocrine agents used in advanced breast cancer. Clin Pharmacokinet. 1992;22(5):327-358.
6. Love RL, Mazess RB, Barden HS, et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. NEJM. 1992;3326:852-856.
7. Rutqvist LE, Mattson A. Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. J Natl Cancer Inst. 1993;85:1398-1406.
8. Fisher B, Constantino JP, Redmond CK, et al. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst. 1994;86:527-537.
9. Fornander T, Rutqvist LE, Cedermark B, et al. Adjuvant tamoxifen in early-stage breast cancer: effects on intercurrent morbidity and mortality. J Clin Oncol. 1991;9:1740-1748.
10. Pathak DN, Bodell WJ. DNA adduct formation by tamoxifen with rat and human liver microsomal activation systems. Carcinogenesis. 1994;15(3):529-532.
11. Jensen EV, Block GE, Smith S. et al. Estrogen receptors and breast cancer response to adrenalectomy. Natl Cancer Inst Monograph. 1971;34:55-71.
12. Groom GV, Griffiths K. Effect of the anti-oestrogen tamoxifen on plasma levels of luteinizing hormone, follicle stimulating hormone, prolactin, oestradiol, and progesterone in normal pre-menopausal women. J Endocrinology. 1976;70:421-428.
13. Sherman BM, Chapler FK, Crickard K, et al. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women. J Clin Invest. 1979;64:398-404.
14. Jordan VC, Fritz NF, Tormey DC. Endocrine effects of adjuvant chemotherapy and long term tamoxifen administration on node-positive patients with breast cancer. Cancer Res. 1987;47:624-630.
15. Rose DP, Davis TE. Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients. Cancer Res. 1980;40:4043-4047.
16. Manni A, Trajillo JE, Marshall JS, et al. Antihormone treatment of stage IV breast cancer. Cancer. 1979;43:444-450.
17. Jordan VC, Fritz NF, Langan-Fahey S, et al. Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent. J Natl Cancer Inst. 1991;83:1488-1491.
18. Lippman M, Bolan G, Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 1976;36:4595-4601.
19. Osborne CK, Hobbs K, Clark GM. Effects of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res. 1985;45:584-590.
20. Beex L, Pieters G, Smals A, et al. Tamoxifen versus ethinyl estradiol in the treatment of postmenopausal women with advanced breast cancer. Cancer Treat Rep. 1981;65:179-185.
21. Ingle JN, Ahmann DL, Green SJ, et al. Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer. NEJM. 1981;304:16-21.